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Abstract 
Matrix vesicles are fundamental components of 
initial mineral formation in endochondral and primary 
ossification. Regulation of their structure and function 
is multi-faceted and involves genomic and nongenomic 
pathways. Their function in mineralization may include 
matrix maturation and conveying cellular signals to the 
extracellular matrix as well. Intravesicular hydroxyapa-
tite crystal formation is associated with primary mineral-
ization; subsequent crystal formation, particularly at 
later stages, appears to be mediated by other mecha-
nisms. 
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Introduction 
Primary mineralization is regulated by chondrocytes, 
osteoblasts, and odontoblasts and is observed in epi-
physeal cartilage, embryonic bone, post-fetal ossifi-
cation, and repair and development of predentine, and 
bone induction. In all these instances a tight regulation 
of the process in both time and space is required. 
Intravesicular crystals are seen prior to bulk phase 
mineral deposition, suggesting that matrix vesicles have 
a role in the initiation of calcification [1, 2, 8, 17, 59, 
72]. While mineral crystals are first seen in matrix vesi-
cles [3, 8, 14, 15, 72] it is unlikely that bulk phase min-
eral deposition requires vesicles or their constituents 
[35]. However, the involvement of matrix vesicles is 
believed to be an important factor in maintaining calcifi-
cation cellular control. How this is accomplished will 
be discussed below. 
The accepted method for isolation of matrix vesicles 
is by collagenase digestion of the calcifying tissue, fol-
lowed by differential centrifugation [1, 4, 72, 74]. 
However, for frozen samples or tissues which are heter-
ogeneous, this is not a useful approach. For these latter 
instances, tissue homogenization followed by density 
gradient centrifugation was found to be preferable [12, 
30]. Using both differential centrifugation and/or den-
sity gradient centrifugation techniques, a number of bio-
chemical characteristics of matrix vesicles have been 
identified. Matrix vesicles have lipid compositions dis-
tinct from the cell in general [ 4 7, 71] and from the 
plasma membrane [38, 60, 74]. Alkaline phosphatase, 
long associated with calcification [69] is the organelle's 
marker enzyme [2, 9, 43]. Matrix vesicles continue to 
mature concomitant with maturation of the growth plate; 
for instance, their mineral ion composition changes [74] 
and proteolipid [22] and Ca-phospholipidphosphatecom-
plex (CPLX) content [73] increases. Their composition 
and enzyme activity was shown to be regulated by hor-
mones known to regulate calcification [25]. 
Although isolated matrix vesicles support hydroxy-
apatite formation in vitro [9, 72], a critical question in 
the biogenesis of matrix vesicles has been whether or not 
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Figure 1: Transmission electron 
micrograph photographed from 
television monitor to demonstrate 
the method for morphometric 
quantitationof extracellular matrix 
vesicles in healing bone. Typing 
and measurement of diameter and 
distance from the calcified front is 
performed by vesicular detection 
with a pointing device ( +) to en-
circle their outline and delineation 
of the calcified front (arrow). 
Transopaque matrix vesicle is 
indicated by an arrowhead and 
transparent matrix vesicle by an 
open arrowhead. Photo width = 
5.7 µ.m. 
they are "preloaded" with calcium and phosphate at the 
time of their release. Specific interactions of Ca2+ and 
phosphate ions with phospholipids in the cell membrane 
could result in the formation of CPLX [28] . Phospho-
lipid-mineral interactions may be responsible for mem-
brane fusion, allowing vesicular budding into the extra-
cellular matrix [37, 72] . The occurrence of actin in iso-
lated vesicle fractions is indicative of a cytoskeletal role 
in vesicle formation as well [45, 61, 72]. 
Whether multiple subclasses of matrix vesicles are 
produced by a single cell at a specific stage of differ-
entiation or whether each cell produces only one class of 
vesicle is unknown. The continuing maturation of the 
vesicles in the extracellular matrix could also add to 
their apparent heterogeneity. Immediately after release, 
vesicles appear electron lucent, although Ca and phos-
phate may already be present. Following further uptake 
of calcium and phosphate, vesicle morphology is amor-
phous, homogeneous, and electron-opaque. Calcification 
on the internal surface of the membrane follows . Rup-
ture of the vesicular membrane follows crystal growth. 
In the matrix, released crystals adhere to each other and 
serve as foci for continued crystal deposition, and 
calcospherite formation [59]. 
Changes in Matrix Vesicle Morphology and 
Biochemistry in Bone Healing 
Removal of the marrow tissue in rat tibial bone has 
been developed as an animal model of primary minerali-
zation during bone healing. Following injury, endosteal 
bone formation is activated. This process has been mon-
154 
itored as a function of time in perfusion-fixed tissue 
using computerized cytomorphometry [59, 60]. Matrix 
vesicles were sorted according to their type, diameter 
and distance from the calcified front [5, 6, 54, 59, 60, 
62, 63]. Electron lucent vesicles were categorized as 
"empty"; those with amorphous electron opaque contents 
as "amorphous" ; those containing crystalline structures 
as "crystalline"; and those with ruptured membranes and 
released crystals as "rupture" (Fig. 1). 
These studies supported the hypothesis that cells are 
responsible for the production of electron lucent vesicles 
that continue to accumulate Ca and inorganic phospho-
rous (Pi), and acquire "amorphous-type" characteristics. 
Hydroxyapatite crystals form, followed by membrane 
rupture and exposure of the crystals to the matrix. Most 
vesicles were found within 3 µ.m from the calcified 
front. "Rupture" vesicles were closest to the front and 
had the largest diameter [59]. Matrix vesicle maturation 
on each day of healing was characterized by increased 
vesicular diameter and was accompanied by increased 
numbers of mature vesicles of the "crystal" and "rup-
ture" types and decreased numbers of the "empty" and 
"amorphous" types [59]. 
Changes in matrix vesicle morpbometry correlate 
with biochemical changes in matrix vesicle-enriched 
microsomal fractions (MVEM) isolated from the healing 
tissue. At six days post-injury, there is an increase in 
MVEM alkaline phosphatase and phospholip~ A2 spe-
cific activities (Fig. 2) [57]. Phospholipid composition 
changes with time. The amount of phosphatidylcholine 
decreases as a function of time. Phosphatidylserine con-
tent is greatest at days 6 and 14, which correlates with 
Matrix Vesicles 
Q) 15 15 Q) 
-+-' 
* * 
-+-"' 
::J 
::J l c c ·-·- ::E ~ 
. . .. . . . . . . . . . . .. . .•. . . . t:::i. ............ 
'-.... c 
·-r· ... c ~ 10 10 Q) ·- -+-" Q) 
* ---------· ·. 
0 ~ 
-+-' 
• 
L <J 0 a... 
L 
I o_ 1 Cl E 01 • ............ <] E ...._,, 5 * Ul ...._,, 
" 
5 
·-
I Ul 
0... T/ ·1 ~ 
• 
0 
L 
0 /; • -0 E l ~ I 
::t 0 o ~ 
0 5 10 15 20 25 
Days of Treatment 
Figure 2: Specific activities of alkaline phosphatase expressed as µmol P/mg protein/minute and phospholipase A2 
expressed as percent hydrolysis/mg protein/minute in matrix vesicle-enriched membranes isolated from tibial bone heal-
ing following marrow ablation. Isolation is performed by differential centrifugation of homogenates of the newly 
formed tissues. Values are presented as means ± standard error of mean (S.E.M.) for six samples, each sample com-
posed of pooled tissue of six animals. *: statistically significant; p < 0.05 for each time point compared to time 0. 
the onset of calcification in the tissue and may reflect its 
role in the initiation of hydroxyapatite formation as a 
constituent of matrix vesicle proteolipids and CPLX. 
Matrix vesicle morphometrics and MVEM bio-
chemical parameters are sensitive to regulation in vivo. 
When bone-bonding and non-bonding ceramic and metal 
implants were inserted into the marrow-ablated tibia, 
changes were observed in the normal healing pattern, 
both in the treated leg and in MVEM isolated from the 
contralateral limb [7, 44, 53]. Bone-bonding materials 
stimulated MVEM alkaline phosphatase specific activity 
and increased matrix vesicle density in the treated limb 
at early time points. While MVEM alkaline phosphatase 
behaved like that seen in normal healing at later times, 
matrix vesicle concentration (#/µm2) was decreased with 
respect to normal. MVEM phospholipase A2 specific 
activity was lower in tissue adjacent to the bone-bonding 
implants and was markedly inhibited in the contralateral 
limb. 
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The implant-dependent decrease in MVEM phospho-
lipase A2 activity was even more marked in the tissue 
adjacent to nonbonding implants; there was no MVEM 
phospholipase A2 activity in the contralateral limb. 
MVEM alkaline phosphatase specific activity became 
only slightly elevated during healing, but no differences 
in magnitude between treatment and control limbs were 
evident. Matrix vesicle density was either comparable 
to that of normal healing bone or was depressed. These 
data demonstrate that there is both local and systemic 
regulation involved. 
Role of Matrix Vesicle Components in 
Mineral Deposition 
The data presented above show that changes in alka-
line phosphatase or phospholipase A2 activities can be 
correlated with altered matrix vesicle function in vivo. 
Other components of the vesicle are now known to play 
a role in the calcification process. Most information is 
]. Sela, Z. Schwartz, L.D. Swain et al. 
derived from studies of cartilage and cartilage cells. Ini-
tial sites of hydroxyapatite deposition are observed on 
the inner vesicle membranes [1-3, 9]. CPLX and pro-
teolipids, shown to support calcification in vitro [16, 17, 
23, 50], have been isolated from matrix vesicles [23, 
73], suggesting that they could function as mineralization 
initiation sites. Other observations support this hypothe-
sis. CPLX is present at sites where mineralization is 
about to occur or has just started, as evidenced in hyper-
trophic cartilage, metaphyseal bone, fracture callus, and 
following induction of heterotopic bone formation [10, 
16-20]. Proteolipids are enriched in matrix vesicles and 
participate in formation of CPLX, in part by structuring 
phosphatidylserine [21, 22]. Proteolipids may also act 
as ionophores, exporting protons and importing calcium 
and phosphate [27, 68]. 
Enzymes like alkaline phosphatase, pyrophospha-
tase, ATPase, phospholipase A2, and NTP-pyrophospho-
hydrolase, which exhibit increased activity as the growth 
plate mineralizes, have been localized to matrix vesicles 
[32, 33, 38, 70] and are regulated by factors which 
monitor calcification [24, 55, 56, 58]. Robison [52] 
first observed the relationship between bone formation 
and increased alkaline phosphatase and postulated a role 
in raising local concentrations of Pi [9, 40]. It is pos-
sible that more than one matrix vesicle alkaline phospha-
tase exists [11], each with a distinct function. 
Other matrix vesicle proteins appear to play a role 
in calcification. Uptake of mineral ions by isolated 
matrix vesicles incubated in synthetic cartilage lymph 
has been shown to follow a consistent pattern. After an 
initial lag, vesicles rapidly accumulated ea2+ and Pi, an 
ability readily destroyed by proteases. A subset of 
EGTA-extractable proteins selectively bound Ca2+ in the 
presence of lipids and cross-reacted with antibodies to 
calpactin II, suggesting that this protein was involved in 
ion uptake [34]. 
Matrix maturation is important in the cascade of ex-
tracellular events which lead to bulk phase hydroxyapa-
tite formation. Mineralization of the matrix involves 
proteoglycan degradation [26, 32, 41, 42], including ag-
gregate breakdown, proteolysis of the core protein, and 
glycosaminoglycan degradation [48, 49]. Cytochemical 
studies [71] suggest that glycosaminoglycan loss is medi-
ated by matrix vesicles. Proteases are present in matrix 
vesicles [29, 38], suggesting that they participate in 
matrix processing. Their distribution is cell maturation-
dependent; neutral and acid metalloproteinase activity is 
highest in matrix vesicles produced by growth zone 
chondrocytes [29]. Since a significant percentage of the 
metalloproteinases are in active form, breakdown of the 
matrix vesicle may be the event which releases these 
enzymes for matrix maturation and subsequent calci-
fication. 
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Regulation of Matrix Vesicle Mineral Formation 
Membrane phospholipids are subject to regulation 
by a number of enzymes; thus, their metabolism can in-
fluence the structure and function of matrix vesicles (39, 
64-66]. Phospholipase A2 activity increases commensu-
rate with maturation of the growth plate (70]. In matrix 
vesicles isolated from cultured chondrocytes, enzyme ac-
tivity is higher in growth vesicles produced by growth 
zone cells than in vesicles produced by resting zone cells 
[55]. This enzyme catalyzes the rate-limiting step in 
prostaglandin production [13, 36], and is also required 
for fatty acid turnover, resulting in changes in mem-
brane fluidity. This can have consequences for ion 
transport and enzyme activity (46, 51]. The fluidity of 
the membrane can alter its structural characteristics (31] 
ultimately changing the ability to support mineralization. 
Another role for phospholipases in vesicles may be to 
degrade membrane phospholipids, resulting in loss of 
vesicle integrity [67, 72]. Those lipids which have 
formed mineral complexes appear to be resistant to the 
action of phospholipases [50]. This may explain the 
difference in susceptibility to hydrolysis observed when 
phospholipids isolated from plasma membranes or matrix 
vesicles are incubated with exogenous phospholipases 
[58]. 
Other matrix vesicle enzymes may play roles in re-
moval of mineralization inhibitors (32]. ATP and other 
nucleotide triphosphates are present in matrix vesicles 
and inhibit crystal growth. Their hydrolysis by NTP-
pyrophosphohydrolase (32] generates pyrophosphate, an-
other polyphosphate inhibitor, subsequently degraded by 
pyrophosphatase. As hydrox yapatite crystals grow, pro-
tons are released, potentially lowering local pH. One 
function of matrix vesicle carbonic anhydrase may be to 
prevent this acidification. Other proteins are present, 
such as actin [45] but probably do not have a role in 
mineral deposition. 
The suggested chain of events and their localization 
in the extracellular matrix, on the vesicular membrane, 
and within its lumen support the current hypothesis on 
the active role of matrix vesicles in the initiation of 
mineralization (Fig. 3). 
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Disc~ion with Reviewers 
Reviewer I: Matrix vesicles are extracellular - how can 
they keep calcification under cell control? 
Authors: Recent studies have shown that matrix vesi-
cles are under autocrine regulation by chondrocytes. 
These cells produce vitamin D metabolites which have 
direct, nongenomic effects on the matrix vesicle mem-
brane. In effect, the cell is able to regulate events in the 
matrix by remote control. While l ,25-(0H)iD3 and 
24,25-(0H)iD3 have comparable effects on isolated 
matrix vesicles and plasma membranes, the effects are 
seen only in the matrix vesicles and not in the plasma 
membranes isolated from intact cells incubated with hor-
mone. These data suggest that the cbondrocyte can 
down regulate any effects on the cell, whereas, the 
matrix vesicle is unable to do so. In this manner, the 
cell is able to synthesize the matrix vesicle under 
genomic control and then regulate its activity later by 
nongenomic mechanisms. 
T .A. Einhorn: The authors note that, in addition to 
their role in mineralization, matrix vesicles may be 
involved in various biochemical events which take place 
during the degradation of proteoglycan aggregates. 
These proteolytic activities are presumed to be necessary 
in order to create the necessary biochemical environment 
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such that mineralization may proceed. Have the authors 
considered the possibility that these matrix-vesicle 
associated proteases may also be involved in the binding 
or activation of growth factors or cytokines? 
Authors: Dr. Einhorn raises an interesting point. Pre-
liminary data from our laboratory suggest that matrix 
vesicle enzymes do play a role in activation of cytokines 
in the matrix. 
T .A. Einhorn: The authors imply that the lipid content 
of matrix vesicles is distinct from the cell in general and 
the plasma membrane. If this is true, what is the origin 
of the matrix vesicle in relation to the cell? How does 
it form? Is its trilaminar membrane similar to that found 
in chondrocytes or osteoblasts or is it unique to the 
matrix vesicle? 
Authors: The phospholipid composition of matrix vesi-
cles differs quantitatively from that of the plasma mem-
brane from which it is derived. This may be due to 
formation of specific phospbolipid domains prior to the 
release of the matrix vesicle from the plasma membrane. 
Another mechanism may be phospholipid metabolism in 
the matrix vesicle itself. 
T.A. Einhorn: Various investigators have suggested 
that matrix vesicles are nothing other than artifacts of 
tissue preparation. What evidence do the authors have 
that this is not the case and that matrix vesicles are true 
physiological entities? 
Authors: In early descriptions of matrix vesicles they 
were compared biochemically to the chondrocyte pellet. 
Not surprisingly, they exhibited enrichment of alkaline 
phosphatase since they represented a relatively pure pop-
ulation of membranes and the plasma membrane alkaline 
phosphatase of the cell was diluted by other cellular 
constituents. This may have led to some of the confu-
sion concerning the concept of matrix vesicles as "dy-
namic cell debris" versus a legitimate extracellular 
organelle. In our studies, matrix vesicles are compared 
to purified plasma membranes. Because they are extra-
cellular, homogenization of the tissue is not needed for 
their isolation following enzymatic degradation of the 
extracellular matrix. They can be easily separated from 
the cells by gently pelleting the latter. The cells are 
more than 95 % viable by trypan blue dye exclusion sug-
gesting that fragmentation of the plasma membrane is 
minimal. The matrix vesicles isolated in this manner are 
"right side out." It is necessary to homogenize the cells 
in order to purify the plasma membranes. When the 
plasma membranes are isolated, they may be inside out 
or right side out. If matrix vesicles were fragments of 
the plasma membrane, they would also be one-half in-
side out and one-half outside out and alkaline phospha-
tase activity would equal that of the plasma membrane. 
Matrix Vesicles 
If enrichment of enzyme activity were only two-fold, 
positive identification would still not be possible, since 
the vesicles could have been formed by trypsiniz.ation 
and be right side out. For this reason, the alkaline phos-
phatase specific activity of the matrix vesicles must be 
more than twice that of the plasma membranes m order 
for them to be considered by us to be "true physiological 
entities. " In many of our preparations, the alkaline 
phosphatase specific activity of the matrix vesicles is ten 
times that of the plasma membranes. 
This quality control is not possible when using ma-
trix vesicle-enriched microsomes prepared from homoge-
nized tissue. In order to isolate the purest matrix vesi-
cles possible, both differential and density gradient cen-
trifugation are used. The matrix vesicles that are ob-
tained using this methodology are comparable to the 
ones that are obtained using the methods described 
above. While it is not possible to rule out that we have 
merely isolated an alkaline phosphatase-rich domain of 
the plasma membrane, the similarity of the composition 
of matrix vesicle-enriched microsomes with the matrix 
vesicles isolated from enzymatically digested tissue, 
argues that we have not. 
J.M. Shapiro: It is difficult to understand why the 
authors utilize a high speed fraction (MVEM), derived 
from the tissue homogenate as a substitute for native ma-
trix vesicles. The homogenate would contain many cell 
types and, therefore, many different kind of vesicles 
would be generated. Moreover, as the MVEM which is 
mainly endoplasmic reticulum, it would have a different 
lipid and protein composition from plasma membrane, 
which in tum is different from that of the matrix vesicle. 
Would it not be better to use either a plasma membrane 
fraction or isolated vesicles for the studies described in 
the manuscript? 
Authors: We agree that the MVEM are not the fraction 
of choice if one wants to study matrix vesicles. We 
used MVEM because the tissues from which we isolated 
them were frozen to permit transfer from Israel to the 
USA. The result was freeze/thawed tissue, itself some-
what homogenized, and, therefore, classical matrix vesi-
cle isolation techniques were precluded. A further com-
plication was the difference in consistency in the tissues 
with time. Homogeniz.ation eliminated some of the vari-
ation. Some confusion may result from the term "mi-
crosomes," which to many biochemists implies rough or 
smooth endoplasmic reticulum. Certainly rough endo-
plasmic reticulum can be ruled out, as there is no RNA 
present in the matrix vesicle preparation. Microsomes 
can also refer to any membrane preparation that forms 
vesicles under aqueous conditions. We are confident 
that the MVEM were a highly enriched fraction and that 
endoplasmic reticulum contamination, or of any other 
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subcellular membrane organelle, was quite low, based 
on marker enzyme studies. 
We chose not to use the plasma membrane fraction 
because other studies in our laboratory have shown that 
the plasma membrane is regulated in a differential man-
ner from the matrix vesicles, and it was matrix vesicles 
we were interested in based on our cytomorphometric 
studies. 
J.M. Shapiro: While it is very interesting that bone 
cells secrete matrix vesicles and mineral is present in the 
vesicles at sites of repair, mineral is also seen in colla-
gen. Would the authors please provide some informa-
tion on the relationship between matrix vesicle and col-
lagen mineraliz.ation at these repair sites? In addition, 
are values for matrix vesicle related to values obtained 
for other components of the matrix? 
Authors: Whether or not the mineral present in matrix 
vesicles is directly related to mineral on the collagen 
fibrils has not been satisfactorily resolved. It is our 
hypothesis that the mineral within the vesicle is involved 
in its breakdown and the subsequent release of proteases 
needed to modify the matrix for bulk phase mineraliz.a-
tion. At the transmission electron microscopy level, it 
appears that at least some of the mineral present in the 
matrix vesicles contributes to calcospherite formation. 
J.M. Shapiro: The data on phospholipase activities at 
mineralizing sites is of considerable interest. Why was 
there inhibition of phospholipase activity in tissue close 
to implants, etc.? Does this imply that there exists in 
the extracellular matrix a local phospholipase inhibitor; 
alternatively, does the implant modulate osteoblast endo-
plasmic reticulum enzyme activity (MVEM) and this re-
sults in modification in matrix vesicle lipase activity? 
Authors: We are also intrigued by the regulation of 
phospholipase A2• We are presently examining the ef-
fects of specific phospholipase A2 activators and inhibi-
tors to try to dissect the problem more effectively. 
